Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma

Abstract The standard of care for patients with locoregionally advanced nasopharyngeal carcinoma is concurrent platinum-based chemoradiotherapy. Existing literature have demonstrated that the addition of gemcitabine and cisplatin as induction chemotherapy in locoregionally advanced nasopharyngeal ca...

Full description

Bibliographic Details
Published in:	Cancer Communications
Main Authors:	Yuan Zhang, Ying Sun, Jun Ma
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Subjects:	Gemcitabine Cisplatin Induction chemotherapy Nasopharyngeal carcinoma
Online Access:	http://link.springer.com/article/10.1186/s40880-019-0385-5

Similar Items

Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Jiangping Yang, et al.
Published: (2020-12-01)

The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma
by: Xiao‐Min Li, et al.
Published: (2022-09-01)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Wen-Fei Li, et al.
Published: (2016-11-01)

Efficiency of high cumulative cisplatin dose in high‐ and low‐risk patients with locoregionally advanced nasopharyngeal carcinoma
by: Yu‐Ting Jiang, et al.
Published: (2022-02-01)

Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failure
by: Xing-Li Yang, et al.
Published: (2022-11-01)

Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
by: Lin-Feng Guo, et al.
Published: (2025-08-01)

A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin
by: Zhiyuan Xu, et al.
Published: (2022-04-01)

Long-term results of locoregionally advanced nasopharyngeal carcinoma treated with cisplatin and 5-fluorouracil induction chemotherapy with or without docetaxel in young and middle aged adults
by: Yuming Zheng, et al.
Published: (2025-03-01)

Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
by: Ying Li, et al.
Published: (2023-04-01)

Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy
by: Lin-Feng Guo, et al.
Published: (2025-09-01)

Cost-effectiveness of nivolumab plus gemcitabine-cisplatin as first-line treatment for advanced urothelial carcinoma in China and the United States
by: Guiyuan Xiang, et al.
Published: (2024-09-01)

Comparison of Two Standard Treatment Approaches in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Issa Mohamad, et al.
Published: (2022-07-01)

Clinical Efficacy of Gemcitabine plus S-1 on Refractory Nasopharyngeal Carcinoma Patients and Their Influence on Immune Function
by: CHEN Jinghua, et al.
Published: (2018-12-01)

Prediction of induction chemotherapy response in locoregionally advanced nasopharyngeal carcinoma based on three pretreatment non-Gaussian diffusion MRI models
by: Huanhuan Ren, et al.
Published: (2025-07-01)

Individualized number of induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma patients based on early tumor response
by: Yu‐Ting Jiang, et al.
Published: (2023-02-01)

Efficacy and Toxicity of Pemetrexed or Gemcitabine Combined with Cisplatin in the Treatment of Patients with Advanced Non-small Cell Lung Cancer
by: Xingsheng HU, et al.
Published: (2012-10-01)

Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Hua Zheng, et al.
Published: (2023-07-01)

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma
by: Sai-Lan Liu, et al.
Published: (2018-12-01)

Gemcitabine and cisplatin regimen facilitates prognosis of advanced nasopharyngeal carcinoma
by: Qiongxuan Li, et al.
Published: (2018-07-01)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
by: Horace Cheuk-Wai Choi, et al.
Published: (2021-02-01)

Clinical Observation of Concurrent Radio-Chemotherapy Combined with Adjuvant Chemotherapy in Treating Locoregionally Advanced Nasopharyngeal Carcinoma
by: Yan-ping CHEN, Yun-cong LIU, et al.
Published: (2010-02-01)

Survival after induction chemotherapy in locoregional advanced nasopharyngeal carcinoma: An updated systematic review and meta‐analysis
by: Yiyu Meng, et al.
Published: (2023-10-01)

A Randomized, Controlled, Multicenter Clinical Trial Comparing Pemetrexed/Cisplatin and Gemcitabine/Cisplatin as First-line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer
by: Yan HUANG, et al.
Published: (2012-10-01)

A nomogram integrating clinical stage and pre-EBV DNA to identify the cycles of induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Sunqin Cai, et al.
Published: (2025-06-01)

Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy
by: Da-wei Zhao, et al.
Published: (2021-11-01)

Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers
by: Hao‐Yun Tao, et al.
Published: (2023-03-01)

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
by: Sai-Lan Liu, et al.
Published: (2020-02-01)

The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma
by: Xiaoyong Xiang, et al.
Published: (2023-04-01)

Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience
by: Shripad B Pande, et al.
Published: (2012-01-01)

Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma
by: Fubin Zhu, et al.
Published: (2023-09-01)

The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis
by: Mei Liu, et al.
Published: (2018-12-01)

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China
by: Zhongqiu Wang, et al.
Published: (2025-02-01)

Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
by: Lanpeng Lu, et al.
Published: (2023-11-01)

Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial
by: Yan Wang, et al.
Published: (2022-11-01)

Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma
by: Yi-Feng Yu, et al.
Published: (2024-06-01)

Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis
by: Hao Peng, et al.
Published: (2018-03-01)

Long-term outcomes of induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
by: Xiaoyan Zhao, et al.
Published: (2024-11-01)

Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01)

Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it
by: Weiling Qu, et al.
Published: (2023-03-01)

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
by: Chiao-En Wu, et al.
Published: (2020-05-01)